Is insulin the new intermittent hypoxia?

Medical Hypotheses

Volumn 82, Issue 6, 2014, Pages 730-735

  Limberg, Jacqueline K ^a   Curry, Timothy B ^a   Prabhakar, Nanduri R ^b   Joyner, Michael J ^a  

^a MAYO CLINIC   (United States)

^b University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADRENERGIC STIMULATION; ARTICLE; CAROTID BODY CHEMORECEPTOR; CENTRAL NERVOUS SYSTEM; FACILITATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INTERMITTENT HYPOXIA; MUSCLE SYMPATHETIC NERVE ACTIVITY; NONHUMAN; SLEEP DISORDERED BREATHING; ADRENERGIC SYSTEM; BIOLOGICAL MODEL; BLOOD; CAROTID BODY; CHEMORECEPTOR CELL; CYTOLOGY; HYPERINSULINISM; INNERVATION; METABOLISM; MUSCLE; PHYSIOLOGY;

CAROTID BODY; CHEMORECEPTOR CELLS; HUMANS; HYPERINSULINISM; INSULIN; MODELS, BIOLOGICAL; MUSCLES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84899633868     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.03.014     Document Type: Article

References (66)

1. Mancia G., Grassi G., Giannattasio C., Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999, 34:724-728.
2. Malpas S.C. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 2010, 90:513-557.
3. Lambert E., Dawood T., Schlaich M., Straznicky N., Esler M., Lambert G. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 2008, 35:503-507.
4. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000, 13:99S-105S.
5. Smith M.M., Minson C.T. Obesity and adipokines: effects on sympathetic overactivity. J Physiol 2012, 590:1787-1801.
6. Narkiewicz K., Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003, 177:385-390.
7. Kumar P., Prabhakar N.R. Peripheral chemoreceptors: function and plasticity of the carotid body. Compr Physiol 2012, 2:141-219.
8. Vallbo A.B., Hagbarth K.E., Torebjork H.E., Wallin B.G. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979, 59:919-957.
9. Wallin B.G., Esler M., Dorward P., Eisenhofer G., Ferrier C., Westerman R., et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992, 453:45-58.
10. Wallin B.G., Thompson J.M., Jennings G.L., Esler M.D. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996, 491(Pt 3):881-887.
11. Peng Y.J., Overholt J.L., Kline D., Kumar G.K., Prabhakar N.R. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A 2003, 100:10073-10078.
12. Peng Y.J., Yuan G., Ramakrishnan D., Sharma S.D., Bosch-Marce M., Kumar G.K., et al. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006, 577:705-716.
13. Peng Y.J., Nanduri J., Yuan G., Wang N., Deneris E., Pendyala S., et al. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci 2009, 29:4903-4910.
14. Xie A., Skatrud J.B., Crabtree D.C., Puleo D.S., Goodman B.M., Morgan B.J. Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 2000, 89:1333-1339.
15. Morgan B.J., Crabtree D.C., Palta M., Skatrud J.B. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 1995, 79:205-213.
16. Vanderveken O.M., Boudewyns A., Ni Q., Kashyap B., Verbraecken J., De Backer W., et al. Cardiovascular implications in the treatment of obstructive sleep apnea. J Cardiovasc Transl Res 2011, 4:53-60.
17. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
18. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332-2335.
19. Imadojemu V.A., Mawji Z., Kunselman A., Gray K.S., Hogeman C.S., Leuenberger U.A. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007, 131:1406-1413.
20. Vollenweider P., Tappy L., Randin D., Schneiter P., Jequier E., Nicod P., et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993, 92:147-154.
21. Scherrer U., Vollenweider P., Randin D., Jequier E., Nicod P., Tappy L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993, 88:388-394.
22. Scherrer U., Randin D., Tappy L., Vollenweider P., Jequier E., Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994, 89:2634-2640.
23. Berne C., Fagius J., Pollare T., Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992, 35:873-879.
24. Anderson E.A., Hoffman R.P., Balon T.W., Sinkey C.A., Mark A.L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246-2252.
25. Scherrer U., Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997, 96:4104-4113.
26. Brown R.T., Polinsky R.J., Baucom C.E. Euglycemic insulin-induced hypotension in autonomic failure. Clin Neuropharmacol 1989, 12:227-231.
27. Spraul M., Ravussin E., Baron A.D. Lack of relationship between muscle sympathetic nerve activity and skeletal muscle vasodilation in response to insulin infusion. Diabetologia 1996, 39:91-96.
28. Hoffman A., Fischer Y., Gilhar D., Raz I. The effect of hyperglycaemia on the absorption of glibenclamide in patients with non-insulin-dependent diabetes mellitus. Eur J Clin Pharmacol 1994, 47:53-55.
29. Vollenweider P., Randin D., Tappy L., Jequier E., Nicod P., Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994, 93:2365-2371.
30. Anderson E.A., Balon T.W., Hoffman R.P., Sinkey C.A., Mark A.L. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992, 19:621-627.
31. Hoffman R.P., Sinkey C.A., Anderson E.A. Hypoglycemic symptom variation is related to epinephrine and not peripheral muscle sympathetic nerve response. J Diabetes Complications 1997, 11:15-20.
32. Vollenweider L., Tappy L., Owlya R., Jequier E., Nicod P., Scherrer U. Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 1995, 44:641-645.
33. Young C.N., Deo S.H., Chaudhary K., Thyfault J.P., Fadel P.J. Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J Physiol 2010, 588:3593-3603.
34. Woods S.C., Seeley R.J., Baskin D.G., Schwartz M.W. Insulin and the blood-brain barrier. Curr Pharm Des 2003, 9:795-800.
35. Margolis R.U., Altszuler N. Insulin in the cerebrospinal fluid. Nature 1967, 215:1375-1376.
36. Banks W.A. The source of cerebral insulin. Eur J Pharmacol 2004, 490:5-12.
37. Banks W.A., Jaspan J.B., Kastin A.J. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 1997, 18:1257-1262.
38. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 1997, 18:1423-1429.
39. Schwartz M.W., Sipols A., Kahn S.E., Lattemann D.F., Taborsky G.J., Bergman R.N., et al. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 1990, 259:E378-383.
40. Schwartz M.W., Bergman R.N., Kahn S.E., Taborsky G.J., Fisher L.D., Sipols A.J., et al. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest 1991, 88:1272-1281.
41. Castillo C., Bogardus C., Bergman R., Thuillez P., Lillioja S. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 1994, 93:10-16.
42. Ward K.R., Bardgett J.F., Wolfgang L., Stocker S.D. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011, 57:435-441.
43. Luckett B.S., Frielle J.L., Wolfgang L., Stocker S.D. Arcuate Nucleus Injection of an Anti-Insulin Affibody Prevents The Sympathetic Response to Insulin. Am J Physiol Heart Circ Physiol 2013, 304(11):H1538-H1546.
44. Cassaglia P.A., Hermes S.M., Aicher S.A., Brooks V.L. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J Physiol 2011, 589:1643-1662.
45. Bardgett M.E., McCarthy J.J., Stocker S.D. Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia. Hypertension 2010, 55:284-290.
46. Rahmouni K., Morgan D.A., Morgan G.M., Liu X., Sigmund C.D., Mark A.L., et al. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 2004, 114:652-658.
47. Muntzel M.S., Anderson E.A., Johnson A.K., Mark A.L. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 1995, 17:39-50.
48. Pereda S.A., Eckstein J.W., Abboud F.M. Cardiovascular responses to insulin in the absence of hypoglycemia. Am J Physiol 1962, 202:249-252.
49. Ribeiro M.J., Sacramento J.F., Gonzalez C., Guarino M.P., Monteiro E.C., Conde S.V. Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets. Diabetes 2013, 62(8):2905-2916.
50. Bin-Jaliah I., Maskell P.D., Kumar P. Indirect sensing of insulin-induced hypoglycaemia by the carotid body in the rat. J Physiol 2004, 556:255-266.
51. Ward D.S., Voter W.A., Karan S. The effects of hypo- and hyperglycaemia on the hypoxic ventilatory response in humans. J Physiol 2007, 582:859-869.
52. Prabhakar N.R. Sensory plasticity of the carotid body: role of reactive oxygen species and physiological significance. Respir Physiol Neurobiol 2011, 178:375-380.
53. Tchobroutsky G., Kopf A., Eschwege E., Assan R. Serial postprandial plasma insulin levels in 117 subjects with and without diabetes. Diabetes 1973, 22:825-833.
54. Reaven G.M., Chen Y.D., Hollenbeck C.B., Sheu W.H., Ostrega D., Polonsky K.S. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993, 76:44-48.
55. Jeppesen J., Hollenbeck C.B., Zhou M.Y., Coulston A.M., Jones C., Chen Y.D., et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995, 15:320-324.
56. Zwillich C.W., Sahn S.A., Weil J.V. Effects of hypermetabolism on ventilation and chemosensitivity. J Clin Invest 1977, 60:900-906.
57. Hollenbeck C., Reaven G.M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987, 64:1169-1173.
58. Marmonier C., Chapelot D., Louis-Sylvestre J. Metabolic and behavioral consequences of a snack consumed in a satiety state. Am J Clin Nutr 1999, 70:854-866.
59. Farshchi H.R., Taylor M.A., Macdonald I.A. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr 2004, 58:1071-1077.
60. Pyorala M., Miettinen H., Laakso M., Pyorala K. Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 2000, 23:1097-1102.
61. Mekary R.A., Giovannucci E., Willett W.C., van Dam R.M., Hu F.B. Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking. Am J Clin Nutr 2012, 95:1182-1189.
62. Wei J.T., Connelly A.E., Satia J.A., Martin C.F., Sandler R.S. Eating frequency and colon cancer risk. Nutr Cancer 2004, 50:16-22.
63. Jakobsson P., Jorfeldt L. Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia. Clin Physiol Funct Imaging 2006, 26:271-274.
64. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008, 134:686-692.
65. Varela J.E., Hinojosa M.W., Nguyen N.T. Resolution of obstructive sleep apnea after laparoscopic gastric bypass. Obes Surg 2007, 17:1279-1282.
66. Paton J.F., Sobotka P.A., Fudim M., Engleman Z.J., Hart E.C., McBryde F.D., et al. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 2013, 61:5-13.